Vitalhub (TSE:VHI – Get Free Report) had its price objective reduced by investment analysts at Stifel Nicolaus from C$11.00 to C$10.00 in a report released on Monday, BayStreet reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus‘s price objective points to a potential upside of 53.37% from the company’s current price.
A number of other equities analysts have also commented on the company. Scotia cut their price target on Vitalhub from C$12.00 to C$9.00 and set a “sector outperform” rating for the company in a report on Monday. TD cut their target price on shares of Vitalhub from C$13.00 to C$9.50 and set a “buy” rating for the company in a research report on Monday. Raymond James Financial reduced their price target on shares of Vitalhub from C$11.00 to C$10.50 and set an “outperform” rating on the stock in a research report on Monday. Canaccord Genuity Group decreased their price target on shares of Vitalhub from C$15.00 to C$14.50 and set a “buy” rating on the stock in a research note on Monday. Finally, National Bank Financial lowered their price objective on shares of Vitalhub from C$12.00 to C$10.00 and set an “outperform” rating for the company in a report on Monday. Nine research analysts have rated the stock with a Buy rating. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of C$10.86.
Check Out Our Latest Analysis on VHI
Vitalhub Stock Performance
Shares of Vitalhub stock traded down C$0.48 during trading hours on Monday, reaching C$6.52. The company’s stock had a trading volume of 481,442 shares, compared to its average volume of 297,780. Vitalhub has a one year low of C$6.46 and a one year high of C$9.77. The company has a market capitalization of C$412.97 million, a P/E ratio of 54.33, a P/E/G ratio of 1.18 and a beta of 1.37. The stock’s fifty day simple moving average is C$7.56 and its two-hundred day simple moving average is C$7.58.
Vitalhub (TSE:VHI – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. The company had revenue of C$31.91 million during the quarter. As a group, research analysts forecast that Vitalhub will post 0.23 earnings per share for the current year.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
